MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
OraSure Technologies Total Liabilities 2011-2026 | OSUR
Annual Total Liabilities OraSure Technologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69.3 M | 52.2 M | 79.8 M | 80.5 M | 55.9 M | 42.2 M | 32.2 M | 38.1 M | 22.1 M | 29.9 M | 30.9 M | 23.1 M | 21.4 M | 27.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 80.5 M | 21.4 M | 43.2 M |
Quarterly Total Liabilities OraSure Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.1 M | 64.3 M | 61.3 M | 69.3 M | 38.5 M | 40.5 M | 41.3 M | 52.2 M | - | 59.5 M | 65.2 M | 79.8 M | 90.3 M | 85.1 M | 70.6 M | 80.5 M | 67.9 M | 60.2 M | 53 M | 55.9 M | 55.9 M | 55.9 M | 55.9 M | 42.2 M | 42.2 M | 42.2 M | 42.2 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 90.3 M | 32.2 M | 55.4 M |
Total Liabilities of other stocks in the Medical instruments industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
17.9 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
18.8 B | $ 20.66 | 1.27 % | $ 10.5 B | USA |
 |
Becton, Dickinson and Company
BDX
|
30.7 B | $ 205.09 | 1.16 % | $ 59 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
13.9 M | $ 8.15 | -7.6 % | $ 164 M | USA |
 |
Luminex Corporation
LMNX
|
308 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
1.53 M | - | -9.52 % | $ 20.6 M | USA |
 |
Harvard Bioscience
HBIO
|
64.3 M | $ 0.66 | -1.92 % | $ 28 M | USA |
 |
iRhythm Technologies
IRTC
|
841 M | $ 188.16 | 0.41 % | $ 5.87 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
93.4 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
1.34 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
85.8 M | - | - | $ 282 M | USA |
 |
Masimo Corporation
MASI
|
1.57 B | $ 138.18 | 0.8 % | $ 7.36 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
2.94 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
2.38 B | - | -0.02 % | $ 16.3 B | USA |
 |
Haemonetics Corporation
HAE
|
680 M | $ 84.98 | 2.36 % | $ 4.28 B | USA |
 |
Alcon
ALC
|
8.79 B | $ 80.67 | -0.38 % | $ 40.4 B |  Schweiz |
 |
Predictive Oncology
POAI
|
5.18 M | $ 6.85 | 3.24 % | $ 37.4 M | USA |
 |
AtriCure
ATRC
|
148 M | $ 42.59 | 1.96 % | $ 2 B | USA |
 |
electroCore
ECOR
|
8.66 M | $ 5.15 | 6.19 % | $ 28.4 K | USA |
 |
ICU Medical
ICUI
|
315 M | $ 152.88 | 1.7 % | $ 3.73 B | USA |
 |
AngioDynamics
ANGO
|
97.2 M | $ 10.02 | -8.29 % | $ 409 M | USA |
 |
The Cooper Companies
COO
|
4.16 B | $ 83.38 | -0.63 % | $ 16.6 B | USA |
 |
Isoray
ISR
|
50.4 M | - | 0.03 % | $ 108 M | USA |
 |
STERIS plc
STE
|
3.53 B | $ 260.64 | 0.52 % | $ 25.7 B | USA |
 |
Glaukos Corporation
GKOS
|
479 M | $ 114.49 | 0.43 % | $ 5.55 B | USA |
 |
InfuSystem Holdings
INFU
|
51.4 M | $ 8.9 | -0.11 % | $ 184 M | USA |
 |
Repro Med Systems
KRMD
|
8.11 M | $ 5.79 | 3.02 % | $ 264 M | USA |
 |
LeMaitre Vascular
LMAT
|
215 M | $ 85.05 | 1.55 % | $ 1.91 B | USA |
 |
Intuitive Surgical
ISRG
|
2.21 B | $ 586.15 | -1.03 % | $ 208 B | USA |
 |
Merit Medical Systems
MMSI
|
1.04 B | $ 93.33 | 1.83 % | $ 5.43 B | USA |
 |
Utah Medical Products
UTMD
|
7.14 M | $ 58.5 | 1.39 % | $ 212 M | USA |
 |
Nephros
NEPH
|
3.5 M | $ 5.07 | -1.74 % | $ 52.7 M | USA |
 |
Microbot Medical
MBOT
|
3.83 M | $ 2.19 | 3.55 % | $ 22.3 M |  Israel |
 |
Milestone Scientific
MLSS
|
3.96 M | $ 0.29 | 2.24 % | $ 23.1 M | USA |
 |
NeuroMetrix
NURO
|
1.01 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
2.62 B | $ 23.52 | 2.53 % | $ 4.05 B | USA |
 |
Pro-Dex
PDEX
|
24.6 M | $ 41.83 | 4.47 % | $ 138 M | USA |
 |
Pulse Biosciences
PLSE
|
14.8 M | $ 14.71 | -3.26 % | $ 707 M | USA |
 |
Repligen Corporation
RGEN
|
866 M | $ 165.12 | -2.32 % | $ 9.2 M | USA |
 |
ResMed
RMD
|
1.74 B | $ 250.85 | 1.07 % | $ 36.6 B | USA |
 |
BioLife Solutions
BLFS
|
50.6 M | $ 24.91 | -1.97 % | $ 1.15 B | USA |
 |
Stereotaxis
STXS
|
20 M | $ 2.57 | -1.35 % | $ 207 M | USA |
 |
Retractable Technologies
RVP
|
73.6 M | $ 0.76 | -0.53 % | $ 22.8 M | USA |
 |
STAAR Surgical Company
STAA
|
112 M | $ 22.43 | 1.08 % | $ 1.1 B | USA |
 |
Teleflex Incorporated
TFX
|
2.82 B | $ 110.0 | -13.07 % | $ 5.15 B | USA |
 |
West Pharmaceutical Services
WST
|
961 M | $ 274.0 | -1.62 % | $ 20 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
3.81 B | $ 12.53 | 1.25 % | $ 2.55 B | USA |